Target intelligence / Profile preview

RNY3 pseudogene 16 (RNY3P16)

Target
RNY3P16
Molecular classification
Pseudogene, Non-coding RNA (Y RNA family)
01

Overview

RNY3 pseudogene 16 (RNY3P16) is a genomic pseudogene located on the X chromosome (chrX:119456558-119456658 hg38). It is classified as a non-coding RNA pseudogene derived from the RNY3 gene, which itself is a member of the Y RNA class. Pseudogenes are generally considered non-functional remnants of once-functional genes, though a minority can contribute to regulatory non-coding RNA pools or epigenetic phenomena. There is currently no evidence that RNY3P16 encodes a functional RNA, protein, or has a direct molecular role in physiological or disease processes. The parent gene, RNY3, is involved in modulating RNA stability and immune pathways and can interact with the Ro60 protein; however, these functions have not been ascribed to this or other specific RNY3 pseudogenes. This molecule is not considered a therapeutic or molecular target (such as a receptor, enzyme, or biomarker) due to a lack of evidence for a functional role, clinical biomarker activity, or druggability, and should not be used as a therapeutic target in drug discovery or molecular biology workflows.

Other names
RNY3P16RNA, Ro-associated Y3 pseudogene 16RNY3 pseudogene 16
02

Mechanism of action

Not applicable

03

Biological functions

None defined for RNY3P16; parent Y RNAs have roles in RNA processing and immune regulation
04

Disease associations

None for RNY3P16; parent gene implicated in cancer, immune disease, and other functions

Beyond the preview

Go deeper on RNY3 pseudogene 16 (RNY3P16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNY3 pseudogene 16 (RNY3P16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call